Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
Sinovac Biotech Shareholders Equity (Quarterly): 8.649B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 8.649B |
June 30, 2024 | 8.649B |
December 31, 2023 | 8.709B |
June 30, 2023 | 8.665B |
June 30, 2023 | 8.665B |
December 31, 2022 | 8.921B |
June 30, 2022 | 9.468B |
December 31, 2021 | 9.327B |
June 30, 2021 | 5.873B |
December 31, 2020 | 746.47M |
September 30, 2020 | 306.39M |
June 30, 2020 | 279.68M |
March 31, 2020 | 283.78M |
December 31, 2019 | 294.02M |
September 30, 2019 | 266.31M |
June 30, 2019 | 266.56M |
March 31, 2019 | 259.10M |
December 31, 2018 | 253.43M |
June 30, 2018 | 163.37M |
December 31, 2017 | 151.15M |
June 30, 2017 | 130.32M |
December 31, 2016 | 115.77M |
September 30, 2016 | 114.96M |
June 30, 2016 | 111.80M |
March 31, 2016 | 123.43M |
Date | Value |
---|---|
December 31, 2015 | 121.65M |
September 30, 2015 | 123.71M |
June 30, 2015 | 127.46M |
March 31, 2015 | 124.75M |
December 31, 2014 | 126.56M |
September 30, 2014 | 125.82M |
June 30, 2014 | 124.81M |
March 31, 2014 | 127.17M |
December 31, 2013 | 128.68M |
September 30, 2013 | 121.73M |
June 30, 2013 | 118.81M |
March 31, 2013 | 116.18M |
December 31, 2012 | 117.72M |
September 30, 2012 | 122.10M |
June 30, 2012 | 124.17M |
March 31, 2012 | 125.00M |
December 31, 2011 | 129.92M |
September 30, 2011 | 126.16M |
June 30, 2011 | 127.31M |
March 31, 2011 | 124.66M |
December 31, 2010 | 126.44M |
September 30, 2010 | 134.97M |
June 30, 2010 | 133.84M |
March 31, 2010 | 132.33M |
December 31, 2009 | 70.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
279.68M
Minimum
Jun 2020
9.468B
Maximum
Jun 2022
5.631B
Average
8.649B
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
CASI Pharmaceuticals Inc | 13.85M |
Zai Lab Ltd | 667.67M |
China SXT Pharmaceuticals Inc | 13.93M |
Adagene Inc | 56.59M |
LakeShore Biopharma Co Ltd | 76.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.90B |
Total Liabilities (Quarterly) | 1.390B |
Debt to Equity Ratio | 0.0358 |
Current Ratio | 11.39 |
Net Debt Paydown Yield | -21.04% |